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Abstract Background: With an increasing volume of primary total shoulder arthroplasties (TSA), the number of
revision TSA cases is expected to increase as well. However,
the postoperative medical morbidity of revision TSA has not
been clearly described. Questions/Purposes: The purpose of
this study was to determine the rate of postoperative complications following revision TSA, relative to primary TSA.
In addition, we sought to identify independent predictors of
complications, as well as to compare operative time and
postoperative length of stay between primary and revision
TSA. Methods: Patients who underwent primary/revision
TSA between 2005 and 2015 were identified in the American College of Surgeons National Surgical Quality Improvement Program. Differences in complications, readmission
rates, operative time, length of stay, and predictors of complications were evaluated using bivariate and multivariate
analyses. Results: A total of 10,371 primary TSA (95.4%)
and 496 revision TSA cases (4.6%) were identified. The
overall complication rate was 6.5% in primary and 10.7%
in revision TSA patients (p < 0.001). Multivariate analysis
identified an increased risk of any complication (odds ratio
1.73, p < 0.001), major complication (2.08, p = 0.001), and
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wound infection (3.45, p = 0.001) in revision TSA patients,
relative to primary cases. Operative time was increased in
revision cases (mean ± standard deviation, 125 ± 62.5),
relative to primary (115 ± 47.7, p < 0.001). Age > 75, female
sex, history of diabetes or chronic obstructive pulmonary
disease, and American Society of Anesthesiologists classification ≥ 3 were associated with increased risk of any complication. Smoking history was the only significant predictor
of wound infection. Conclusion: Revision TSA, in comparison to primary, poses an increased risk of postoperative
complications, particularly wound infections. A history of
smoking was an independent predictor of wound infections.
Keywords primary total shoulder arthroplasty .
revision total shoulder arthroplasty . arthroplasty outcomes .
surgical site infection . complications . ACS NSQIP
Introduction
The Agency for Healthcare Research and Quality predicts that
by 2030, joint replacement will become the most common
elective surgical procedure [1]. The most common of these
procedures are total hip arthroplasty (THA) and knee
arthroplasty (TKA), which exhibited 182 and 231% increases
in procedure volume between 2000 and 2010, respectively, in
the USA [2, 3]. In comparison, shoulder arthroplasty procedure volume has increased by 534% between 2000 and 2010
in the USA [2, 4]. This growth in shoulder arthroplasty volume
may be due in part to the 2003 approval by the Food and Drug
Administration of the reverse shoulder arthroplasty procedure.
The reverse shoulder arthroplasty procedure has increased the
number of indications for arthroplasty, and is frequently used
to treat irreparable rotator cuff tears, cuff tear arthropathy, and
proximal humeral fractures, among other indications [5–7].
There is a reported revision rate of 17.4% (range 0–34%) at
9.4 years from anatomic primary TSA [8, 9], with the most
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common causes of failure including component loosening,
instability, and periprosthetic fractures reported in 6.3, 4.9,
and 1.8% of TSA patients, respectively [9]. Given this failure
rate and the increase in primary shoulder arthroplasty volume,
there will likely be a concomitant increase in the number of
revision shoulder arthroplasty cases in the future.
Previous studies have explored the outcomes of primary
TSA and have found postoperative complication rates between 3 and 14% [10–14]. However, TSA is an overall safe
procedure, with the incidence of mortality after primary TSA
between 0.09 and 0.4% within 30 days of the procedure [11,
12]. In contrast to primary TSA, there is a paucity of large
studies describing the short-term complication rates following revision TSA. Several studies have assessed postoperative complications and outcomes in revision TSA; however,
they either had small single-center cohorts, or lacked a
comparison to primary TSA patients. One study found a
postoperative complication rate of 29.7% at long-term follow-up that included complications such as mechanical failure of the prosthesis and instability, in addition to medical
complications [15]. Another study using the National Hospital Discharge Survey Database (NHDS) compared 1297
primary TSA to 184 revision TSA patients, and found that
revision TSA patients had a longer length of stay and an
increased myocardial infarction rate, but no difference in
other perioperative outcomes compared to primary TSA
patients [16].
Using a large dataset with prospectively collected 30-day
outcomes, the purpose of this study is to determine the
independent association between revision TSA and postoperative complications relative to primary TSA, including
both anatomic and reverse shoulder arthroplasty procedures.
Secondary objectives were to compare operative time and
postoperative length of stay between primary TSA and revision TSA, as well as to identify patient risk factors for
postoperative complications.
Patients and Methods
We used the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). This database contains de-identified patient information from a
random sample of patients from diverse healthcare settings,
ranging from small community hospitals to large academic
medical centers. Data is prospectively collected by a trained
surgical clinical reviewer, and previous studies have demonstrated a 98% interrater agreement rate between reviewers
[17]. Collected variables include demographics, comorbidities, and intraoperative and postoperative complications. As
of 2015, 274 unique variables were collected on each patient
from 603 participating institutions. In recent years, this
database has experienced tremendous growth in the number
of surgical encounters entered into the registry annually. For
instance, in 2005 there were approximately 150,000 unique
surgical encounters, and this has grown to over 880,000 in
2015. Complete methodology on patient inclusion and exclusion criteria, data processing, and quality control measures are described elsewhere [18].
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This study used ACS-NSQIP data from 2005 to 2015.
Primary TSA cases were selected by screening with Current
Procedural Terminology (CPT) codes for primary TSA (CPT
23472); hemiarthroplasty cases were not included in this
study. Revision TSA cases involving either the humeral or
the glenoid component (CPT 23473), and revision involving
both components (CPT 23474), were included in this study.
Primary and revision cases included both anatomic and
reverse procedures. Demographic information that was used
in this study included patient age and sex. Body mass index
was calculated using height and weight, and stratified according to World Health Organization classifications. Comorbidities assessed included diabetes, chronic obstructive
pulmonary disease (COPD), hypertension, smoking history,
and American Society of Anesthesiologists (ASA) classifications, which is another measure of comorbidity burden. A
patient was considered to have a positive smoking history if
they smoked any cigarettes in the year prior to admission for
surgery. Emergency cases and those with contaminated
wound classifications were excluded from this study. Readmission data was only available from 2011 to 2015, and
therefore, the readmission analysis included only patients
from those years.
Postoperative complications that were analyzed included
death, pulmonary complications, deep vein thrombosis or
pulmonary embolism (DVT/PE), stroke or cerebrovascular
accident (CVA), sepsis, return to the operating room after the
initial procedure, wound infections (deep and superficial
surgical site infections), urinary tract infection (UTI), blood
transfusion, and readmission within 30 days of the procedure. Pulmonary complications consisted of failure to wean
from the ventilator postoperatively, unplanned re-intubation,
and pneumonia. Major complications were defined as death,
pulmonary complications, DVT/PE, stroke/CVA, sepsis, or
return to the operating room. Minor complications were
defined as wound infections, UTI, or blood transfusion.
Baseline characteristics and postoperative complications
were compared between primary TSA and revision TSA.
Demographic information was compared using chi-squared
analysis. Postoperative complication data was compared
using bivariate and multivariate binary logistic regression
that controlled for baseline patient characteristics, including
age, sex, BMI, and comorbidities. Operative and postoperative lengths of hospital stay were using Student’s t test.
Finally, multivariate logistic regression was applied to postoperative complications and wound infections with baseline
patient characteristics as covariates to identify preoperative
characteristics that predicted adverse outcomes. Statistical
significance was set at p < 0.05, with Bonferroni corrections
to account for multiple group comparisons. Statistical analysis was performed with SPSS version 23 (IBM Corp.,
Armonk, NY).
Results
There were 10,371 primary TSA (95.4%) and 496 revision
TSA cases (4.6%) in this study. Patients in the revision TSA
group were younger (p < 0.001), were more likely to smoke
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(p < 0.001), and had a higher percentage of patients with an
ASA class of 3 or 4 (p = 0.002) compared to patients in the
primary TSA group (Table 1).
The risk of short-term adverse outcomes, including any
complication and wound infections, were higher for revision
TSA cases (p ≤ 0.001). Patients in the primary TSA group
had a 6.53% incidence of any complication, 2.31% of major
complication, and 4.82% of minor complication (Table 2).
The revision TSA group had a 10.7% incidence of any
complication, 4.64% of major complication, and 7.46% of
minor complications. On bivariate analysis, revision TSA
patients were found to have an increased risk of wound
infections (odds ratio [OR] 4.30, p < 0.001), major complications (OR 2.00, p = 0.001), any complication (OR 1.64,
p < 0.001), and returning to the operating room (OR 2.45,
p < 0.002). On multivariate analysis that controlled for
baseline characteristics, the revision group had an increased
risk of wound infections (OR 3.45, p = 0.001), major complication (OR 2.08, p = 0.001), and any complication (OR
1.73, p < 0.001). No difference in readmission rate was
found between primary and revision TSA on bivariate or
multivariate analysis (OR 1.45, p = 0.12).
Revision TSA cases had a longer operative time than
primary cases (p < 0.001) These revision cases had a mean
operative time (± standard deviation) of 124.6 min (± 62.5),
which was significantly longer compared to primary TSA at
115 min (± 47.7, p < 0.001). No difference was found in
postoperative length of stay between primary TSA
(2.05 ± 3.01 days) and revision TSA (2.12 ± 1.70 days,
p = 0.766).
With multivariate logistic regression using any complication and wound infections as outcomes, age greater than
75 (OR 1.6, p < 0.001), female sex (OR 1.5, p < 0.001), a
history of diabetes (OR 1.4, p < 0.001) or COPD (OR 1.6,
p < 0.001), and ASA class 3 or 4 (OR 1.9, p < 0.001) were
found to significantly increase the risk of any complication

(Table 3). Only a history of smoking (OR 3.0, p < 0.001)
was found to increase the risk of wound infections following
adjustment for patient baseline covariates.
Discussion
The volume of revision TSA is expected to increase significantly in the coming years [9, 19]. Therefore, it is important
to better characterize postoperative outcomes in revision
TSA. Using a large, multicenter, prospectively collected
registry, this study attempted to characterize 30-day postoperative complications and predictive factors for these complications and compare length of operative time and hospital
stay between primary and revision TSA patients. We found
an increase in wound infections, any complication, major
complication, and increased operative time, and identified
preoperative patient risk factors associated with postoperative complications.
There are several limitations to this study. One of the
most important limitations is that ACS-NSQIP only contains
data until 30 days postoperatively, and therefore, we were
only able to assess short-term complications. Assessment of
complication rates between primary and revision TSA at
intermediate- and long-term time points is warranted in
future studies. Furthermore, ACS-NSQIP lacks data regarding variables that are particularly important to TSA, including functional outcomes, the timing of revision TSA relative
to primary TSA, the reason for the revision procedure, and
the inability to differentiate between anatomic and reverse
TSA. While we were unable to differentiate between these
two different shoulder arthroplasty procedures, previous
studies have found that both lead to improvements in functional outcomes [20], and both have similar complication
rates, revision rates, and patient-reported outcomes at the 2year follow-up [21]. However, another study found that

Table 1 Comparison of patient and operative characteristics between primary and revision shoulder arthroplasty
Variable

Age
< 55
55–65
65–75
> 75
Female (%)
Body mass index (kg/m2)
Non-obese (< 30)
Obese I (30–34.9)
Obese II (35–39.9)
Obese III (> 40)
Comorbidities
Diabetes
Smoking
COPD
Hypertension
ASA ≥ 3

All patients
10,867 (100%)

Primary
10,371 (95.4%)

Revision
496 (4.6%)

7.8%
21.8%
13.7%
31.8%
56.3%

7.5%
21.7%
38.8%
32.0%
56.3%

13.3%
24.4%
34.9%
27.3%
55.6%

50.4%
26.2%
13.5%
9.9%

50.4%
26.2%
13.5%
10.0%

51.5%
26.5%
12.7%
9.3%

16.7%
10.5%
6.2%
67.0%
52.6%

16.6%
10.2%
6.2%
67.1%
52.2%

19.8%
16.9%
7.7%
64.3%
59.3%

p value

< 0.001*

Significant values are presented in bold
*Significance defined as p < 0.05

0.766
0.905

0.062
< 0.001*
0.177
0.194
0.002*

26

HSSJ (2018) 14:23–28

Table 2 Comparison of adverse outcomes after primary and revision total shoulder arthroplasty

Any adverse complication
Major adverse complications
Death
Pulmonary complications
DVT/PE
Stroke/cerebrovascular accident
Sepsis
Return to operating room
Minor adverse complications
Wound infection
Urinary tract infection
Blood transfusion
Readmission

Multivariate analysisa

Primary TSA

Revision TSA

Bivariate analysis

n = 10,371

n = 496

OR

p value

OR

p value

6.53%
2.31%
0.17%
0.70%
0.33%
0.11%
0.19%
1.07%
4.82%
0.33%
0.76%
3.87%
2.87%

10.69%
4.64%
0.40%
0.40%
0.40%
0.20%
0.81%
2.62%
7.46%
1.41%
1.41%
5.24%
4.08%

1.64
2.00
2.32
0.57
1.23
1.90
4.18
2.45
1.55
4.30
1.85
1.36
1.42

< 0.001*
0.001*
0.244
0.429
0.775
0.531
0.004
0.001*
0.008
< 0.001*
0.111
0.124
0.120

1.73
2.08
2.56
0.46
1.29
2.06
4.53
2.44
1.59
3.45
1.98
1.38
1.45

< 0.001*
0.001*
0.211
0.589
0.729
0.492
0.007
0.004
0.010
0.001*
0.087
0.125
0.118

Significant values are presented in bold
OR odds ratio, DVT/PE deep vein thrombosis/pulmonary embolism
*Significance defined as p < 0.0038 after correcting for multiple-group comparisons
a
Binary logistic regression

elderly patients older than 80 years had an increased rate of
perioperative complication and blood transfusion requirements in reverse relative to anatomic shoulder arthroplasty
[22]. This subset of patients only composed 12.3% of the
total patients undergoing primary or revision procedure in
our study. Furthermore, we were also unable to control for
variables such as surgeon training and the number of primary or revision TSA procedures that a surgeon or hospital
performs annually, which have been previously demonstrated to have an influence on postoperative outcomes [23], as
these were unavailable in the NSQIP.
Previous studies have also found a high rate of complications in revision TSA patients. In a 2013 case series of 37
patients who had undergone reverse TSA, Boileau et al.
found that 30% of the patients required re-intervention with
a minimum of 2 years follow-up, primarily due to joint
instability, humeral loosening or rotation, and infection
[24]. A 2016 retrospective case-control study by Antoni
et al. also assessed 37 patients who underwent revision

TSA. The authors found a high rate of perioperative complications (54%), primarily due to joint instability and infection, that required re-intervention in 21.6% of patients [15].
Both of these studies had single-center cohorts that lacked
comparisons to a control group, and were also limited by
small sample size.
Additionally, a 2014 retrospective cohort study of
1297 primary TSA and 184 revision TSA patients using
the NHDS database found differences in baseline characteristics between both groups, as well as differences in
postoperative course [25]. The authors found that revision TSA patients were younger, had a longer length of
stay compared to primary TSA patients (3.06 vs
2.46 days), and were more likely to develop a postoperative myocardial infarction. While they had the largest
revision TSA sample size to date, with a control group,
their analysis of outcomes was limited to only the initial
hospitalization, with no information on postdischarge
complications.

Table 3 Independent risk factors for adverse outcomes by multivariate logistic regression
Revision TSA
Any adverse complication

Wound infection

Variable

OR (95% CI)

p value

OR (95% CI)

p value

Age > 75
Female
Obese (BMI > 30 kg/m2)
Diabetes
Smoking
COPD
Hypertension
ASA ≥ 3

1.6 (1.4–1.8)
1.5 (1.3–1.6)
0.81 (0.64–0.97)
1.4 (1.2–1.6)
1.0 (0.78–1.2)
1.6 (1.4–1.9)
1.0 (0.85–1.2)
1.9 (1.7–2.1)

< 0.001*
< 0.001*
0.012
< 0.001*
0.732
< 0.001*
0.921
< 0.001*

0.50 (0.0–1.5)
0.96 (0.30–1.6)
1.4 (0.67–2.1)
1.3 (0.4–2.2)
3.0 (2.3–3.8)
1.0 (0.0–2.3)
0.84 (0.09–1.6)
1.0 (0.37–1.7)

0.153
0.906
0.372
0.598
0.005*
0.910
0.644
0.983

Significant values are presented in bold
OR odds ratio, CI confidence interval, COPD chronic obstructive pulmonary disease, ASA American Society of Anesthesiologists
*Significance defined as p < 0.0063 after correcting for multiple-group comparisons
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In our study of 496 revision TSA and 10,371 primary TSA
patients, the risk of having any 30-day postoperative complication (10.7 vs 6.53%) and major complication (4.64 vs 2.31%)
was increased in revision compared to primary patients, respectively. Studies of revision THA and TKA have also found high
postoperative complication rates as well (7.4 and 4.7%, respectively) that are in line with the findings of this study [26].
Additionally, in our study, wound infections were significantly
more common in revision compared to primary cases (OR 3.45,
p = 0.001), which has also been demonstrated in revision THA
and TKA cases [27]. Our study identified a history of smoking
to be a significant independent risk factor for the development
of postoperative wound infections, which in previous studies
have also shown to increase the risk of postoperative healing
complications in both orthopedic and non-orthopedic surgeries
[27, 28]. In our study, the incidence of wound infections in
revision cases was found to be 1.41%, and is estimated to be 1.7
and 2.9% in revision TKA and THA, respectively, in other
studies [27]. Wound infections in revision shoulder cases, in
comparison to other types of revision joint procedures, may be
due the increased rate of Propionibacterium acne colonization
of the shoulder [29]. This anaerobic bacterium is most commonly found in the pilosebaceous follicles of the upper body,
such as the axilla, and a prior prosthetic implant significantly
increases the risk of infection [30].
Furthermore, this study showed that revision TSA cases
were longer than primary cases (p < 0.001), but did not
identify any differences in postoperative hospital length of
stay. A previous case series of 23 revision TSA patients
described operative length for this procedure at
113 ± 21 min (mean ± standard deviation); however, it
lacked a comparison to primary TSA [31]. Our study also
identified baseline patient characteristics that predict adverse short-term postoperative outcomes, including age
greater than 65, female sex, history of diabetes or COPD,
and high ASA classification (3 or 4). Previous studies
looking at primary TSA patients found age and ASA classification as significant predictors of readmission and adverse outcomes, which are in agreement with this study
[32]. Furthermore, our study showed that obesity (BMI
> 30 kg/m 2 ) does not increase the risk of adverse
postoperative events, which has also been demonstrated in
other studies to not impact short-term outcomes in primary
TSA [25, 33, 34].
In conclusion, revision TSA cases are subject to increases in adverse short-term postoperative events, in particular postoperative wound infections. Additionally, risk
factors including diabetes and smoking history were identified as increasing the risk of adverse postoperative events.
This information is useful to surgeons for preoperative risk
stratification, identifying risk factors that may place patients
at greater risk for complications, and for counseling patients
on surgical outcomes.
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